GCP ClinPlus
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A CRO and central lab service provider supporting clinical development in China.
Diagnostics
Technology Platform
Central laboratory and diagnostic testing platform equipped for biomarker analysis and bioanalytical services to support clinical trial execution.
Opportunities
Beneficiary of the growing number of clinical trials being conducted in China, both by domestic innovators and multinational companies.
Risk Factors
Faces margin pressure and client concentration risks in a competitive service industry dependent on the R&D spending of biopharma clients.
Competitive Landscape
Operates in the competitive CRO and central lab services market, competing on specialized expertise and local knowledge against larger global and domestic players.